279 related articles for article (PubMed ID: 18028277)
1. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates.
Terpstra FG; van 't Wout AB; Schuitemaker H; van Engelenburg FA; Dekkers DW; Verhaar R; de Korte D; Verhoeven AJ
Transfusion; 2008 Feb; 48(2):304-13. PubMed ID: 18028277
[TBL] [Abstract][Full Text] [Related]
2. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
[TBL] [Abstract][Full Text] [Related]
3. Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.
Terpstra FG; Parkkinen J; Tölö H; Koenderman AH; Ter Hart HG; von Bonsdorff L; Törmä E; van Engelenburg FA
Vox Sang; 2006 Jan; 90(1):21-32. PubMed ID: 16359352
[TBL] [Abstract][Full Text] [Related]
4. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.
Mohr H; Gravemann U; Bayer A; Müller TH
Transfusion; 2009 Sep; 49(9):1956-63. PubMed ID: 19497057
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light.
Mohr H; Steil L; Gravemann U; Thiele T; Hammer E; Greinacher A; Müller TH; Völker U
Transfusion; 2009 Dec; 49(12):2612-24. PubMed ID: 19682340
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation.
Trannoy LL; Terpstra FG; de Korte D; Lagerberg JW; Verhoeven AJ; Brand A; van Engelenburg FA
Vox Sang; 2006 Aug; 91(2):111-8. PubMed ID: 16907871
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
[TBL] [Abstract][Full Text] [Related]
8. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
[TBL] [Abstract][Full Text] [Related]
9. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
[TBL] [Abstract][Full Text] [Related]
10. Efficient inactivation of viruses and mycoplasma in animal sera using UVC irradiation.
Kurth J; Waldmann R; Heith J; Mausbach K; Burian R
Dev Biol Stand; 1999; 99():111-8. PubMed ID: 10404882
[TBL] [Abstract][Full Text] [Related]
11. Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates.
van der Meer PF; Gravemann U; de Korte D; Sumian C; Tolksdorf F; Müller TH; Seltsam A
Vox Sang; 2016 Aug; 111(2):127-34. PubMed ID: 27167507
[TBL] [Abstract][Full Text] [Related]
12. Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light.
Ben-Hur E; Chan WS; Yim Z; Zuk MM; Dayal V; Roth N; Heldman E; Lazo A; Valeri CR; Horowitz B
Dev Biol (Basel); 2000; 102():149-55. PubMed ID: 10794102
[TBL] [Abstract][Full Text] [Related]
13. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ
Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
[TBL] [Abstract][Full Text] [Related]
14. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.
Borovec S; Broumis C; Adcock W; Fang R; Uren E
Biologicals; 1998 Sep; 26(3):237-44. PubMed ID: 10208725
[TBL] [Abstract][Full Text] [Related]
15. Viral safety of C1-inhibitor NF.
Terpstra FG; Kleijn M; Koenderman AH; Over J; van Engelenburg FA; Schuitemaker H; van 't Wout AB
Biologicals; 2007 Jun; 35(3):173-81. PubMed ID: 17071103
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
[TBL] [Abstract][Full Text] [Related]
17. In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates.
Dunne WM; Case LK; Isgriggs L; Lublin DM
Transfusion; 2005 Jul; 45(7):1138-42. PubMed ID: 15987359
[TBL] [Abstract][Full Text] [Related]
18. Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19.
Caillet-Fauquet P; Di Giambattista M; Draps ML; Sandras F; Branckaert T; de Launoit Y; Laub R
J Virol Methods; 2004 Jun; 118(2):131-9. PubMed ID: 15081608
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates.
Horowitz B; Rywkin S; Margolis-Nunno H; Williams B; Geacintov N; Prince AM; Pascual D; Ragno G; Valeri CR; Huima-Byron T
Blood Cells; 1992; 18(1):141-9; discussion 150. PubMed ID: 1617188
[TBL] [Abstract][Full Text] [Related]
20. Resistance of surface-dried virus to common disinfection procedures.
Terpstra FG; van den Blink AE; Bos LM; Boots AG; Brinkhuis FH; Gijsen E; van Remmerden Y; Schuitemaker H; van 't Wout AB
J Hosp Infect; 2007 Aug; 66(4):332-8. PubMed ID: 17601636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
